DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020" report to their offering.
The global PVA drugs market is forecast to grow at a CAGR of 7.13% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global PVA drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of drugs (creams, tablets, patches, and rings) used to treat PVA.
The report, Global Post-Menopausal Vaginal Atrophy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the strengths and weaknesses of the key vendors?
- Pfizer Inc.
- Allergan Inc.
- Shionogi & Co. Ltd.
- Novo Nordisk A/S
- Teva Pharmaceutical Industries Ltd
- Foamix Pharmaceuticals
- Ligand Pharmaceuticals
- Pantarhei Bioscience
- Pep-Tonic Medical
- Upsher-Smith Laboratories
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Overview: Vaginal atrophy
PART 06: Branded drug profiles
PART 07: Market landscape
PART 08: Market segmentation by drug class
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Appendix
PART 17: About the Author
For more information visit http://www.researchandmarkets.com/research/2p3bmc/global_post